多重耐药
化学
限制
天然产物
生物信息学
流出
细胞内
P-糖蛋白
癌症研究
抗药性
运输机
计算生物学
对偶(语法数字)
机制(生物学)
ATP结合盒运输机
双重角色
药理学
转录组
癌细胞
对接(动物)
癌症化疗
癌症
米托蒽醌
Abcg2型
肿瘤微环境
优先次序
结构-活动关系
多药耐药相关蛋白
癌症治疗
生物化学
小分子
作者
Leyi Ying,Xin Yu,Lei Li,Jiajia Han,Keren Xu,Yuxing Yao,Wenchao Wang,Yi Hua,Yanlei Yu,Hua Chen,Xiaoze Bao,Qingyong Li,Qihao Wu,Zhikun Yang,Hong Wang
标识
DOI:10.1021/acs.jmedchem.6c02170
摘要
Abstract ATP-binding cassette (ABC) transporters ABCB1/P-glycoprotein (P-gp) and ABCG2/breast cancer resistance protein (BCRP) drive multidrug resistance (MDR) by limiting intracellular chemotherapy accumulation, and are coexpressed in cancers with overlapping substrates. Here, we combine marine natural product fragment mining, artificial intelligence (AI)-based molecular generation, and structure-guided prioritization to design a natural-product-inspired library. Two optimized analogs, Ib18 and It12, reversed P-gp/BCRP-mediated resistance in overexpressing cells, outperforming reference inhibitors. Mechanistic studies confirmed target engagement without expression downregulation. Docking and molecular dynamics simulations provided the structural rationales for dual transporter engagement. Transcriptomics showed Ib18 avoided stress responses triggered by reference inhibitors, supporting an expression-independent MDR-sensitizing mechanism with limited cytotoxicity. In xenografts, Ib18 enhanced the antitumor activity and tumor accumulation of mitoxantrone without detectably increasing systemic toxicity. Together, these findings demonstrate the utility of AI-guided molecular design for overcoming MDR and establish a promising natural-product-inspired chemotype for dual P-gp/BCRP inhibitor.
科研通智能强力驱动
Strongly Powered by AbleSci AI